54 107 (Lithium 300 mg)

Pill imprint 54 107 has been identified as Lithium carbonate extended release 300 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; depression; mania (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 54 107

Lithium carbonate extended release 300 mg 54 107
Lithium carbonate extended release 300 mg 54 107  Front
Lithium carbonate extended release 300 mg 54 107  Back
Lithium carbonate extended release 300 mg 54 107
Lithium carbonate extended release
Imprint:
54 107
Strength:
300 mg
Color:
Beige
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roxane Laboratories, Inc.
National Drug Code (NDC):
00054-0021
Inactive Ingredients:
calcium stearate
povidone
sodium chloride
sodium lauryl sulfate
sorbitol
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
21695-0412 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)